化痰泻火方辅助治疗女童肥胖合并中枢性性早熟痰热内蕴证34例临床观察OA
Clinical Observation on 34 Cases of Huatan Xiehuo Fang(化痰泻火方)as Adjuvant Therapy in Obese Girls of Central Precocious Puberty and Phlegm-Heat Accumulation Pattern
目的 观察化痰泻火方辅助治疗女童肥胖合并中枢性性早熟(CPP)痰热内蕴证的临床疗效.方法 选取2024年3月至2025年9月于陕西中医药大学第二附属医院儿科就诊的肥胖合并CPP痰热内蕴证女童68例,采用非随机同期对照的研究方法分为对照组和治疗组,各34例.对照组皮下注射GnRHa(注射用亮丙瑞林),治疗组在对照组治疗方法的基础上口服化痰泻火方,2组均连续治疗3个月后统计临床疗效.结果 对照组的总有效率为88.24%(30/34),治疗组为94.12%(32/34),2组比较,差异无统计学意义(P>0.05).治疗前,2组的糖脂代谢指标水平比较,差异无统计学意义(P>0.05),具有可比性;治疗后,对照组的总胆固醇(TC)和甘油三酯(TG)水平均显著升高,与同组治疗前比较,差异有统计学意义(P<0.05),血糖、高密度脂蛋白胆固醇(HDL-C)和低密度脂蛋白胆固醇(LDL-C)水平变化不明显(P>0.05);治疗组的血糖、TC、TG和LDL-C水平均显著降低,HDL-C水平均显著升高,与同组治疗前及对照组治疗后比较,差异均有统计学意义(P<0.05).治疗前,2组的影像学指标水平比较,差异无统计学意义(P>0.05),具有可比性;治疗后,2组Tanner分期、卵巢容积、卵泡个数及卵泡最大直径均显著下降,与同组治疗前比较,差异均有统计学意义(P<0.05),2组的子宫长度均变化不明显(P>0.05),治疗组Tanner分期、卵巢容积及卵泡个数下降更显著(P<0.05).治疗前,2组的性激素水平比较,差异无统计学意义(P>0.05),具有可比性;治疗后,2组黄体生成激素(LH)、雌二醇(E2)和治疗组的卵泡刺激激素(FSH)水平均显著降低,与同组治疗前比较,差异均有统计学意义(P<0.05),且治疗组降低更显著(P<0.05),对照组FSH水平变化不明显(P>0.05).治疗组维生素D水平、身高增长速度显著高于对照组,体质量增长速度显著低于对照组,差异均有统计学意义(P<0.05);2组胰岛素样生长因子-1(IGF-1)水平比较,差异无统计学意义(P>0.05).结论 化痰泻火方辅助治疗女童肥胖合并CPP痰热内蕴证,可显著改善其糖脂代谢指标水平、影像学指标、性激素水平及生长发育情况,值得临床推广应用.
Objective To observe the clinical efficacy of the Huatan Xiehuo Fang(化痰泻火方)as adju-vant therapy in obese girls with central precocious puberty(CPP).Methods A total of 68 obese girls with CPP of phlegm-heat accumulation pattern,who visited the department of pediatrics of The Second Affiliated Hospi-tal of Shaanxi University of Chinese Medicine from March 2024 to September 2025,were selected.Using a non-randomized concurrent control study design,they were divided into a control group and a treatment group,with 34 cases in each group.The control group received subcutaneous injections of GnRHa(Leuprorelin for Injec-tion).The treatment group received oral administration of the Huatan Xiehuo Fang in addition to the same treat-ment as the control group.Both groups were treated continuously for 3 months,after which clinical efficacy was assessed.Results The total effective rate was 88.24%(30/34)in the control group and 94.12%(32/34)in the treatment group,with no statistically significant difference between the two groups(P>0.05).Before treat-ment,there was no statistically significant difference in glucose and lipid metabolism indices between the two groups(P>0.05),indicating comparability.After treatment,total cholesterol(TC)and triglyceride(TG)lev-els in the control group significantly increased compared to before treatment within the same group(P<0.05),while blood glucose,high-density lipoprotein cholesterol(HDL-C),and low-density lipoprotein cholesterol(LDL-C)levels showed no significant changes(P>0.05).In the treatment group,blood glucose,TC,TG,and LDL-C levels significantly decreased,and HDL-C levels significantly increased after treatment compared to be-fore treatment within the same group and compared to the control group after treatment(all P<0.05).Before treatment,there was no statistically significant difference in imaging indices between the two groups(P>0.05),indicating comparability.After treatment,Tanner stage,ovarian volume,follicle count,and maximum follicle diameter significantly decreased in both groups compared to before treatment within the same group(all P<0.05),while uterine length did not change significantly in either group(P>0.05).The decreases in Tanner stage,ovarian volume,and follicle count were more significant in the treatment group(P<0.05).Before treat-ment,there was no statistically significant difference in sex hormone levels between the two groups(P>0.05),indicating comparability.After treatment,luteinizing hormone(LH),estradiol(E2),and follicle-stimulating hormone(FSH)levels in the treatment group significantly decreased compared to before treatment within the same group(all P<0.05),and the decreases were more significant compared to the control group(P<0.05).FSH levels in the control group did not change significantly(P>0.05).Vitamin D levels and height growth ve-locity in the treatment group were significantly higher than those in the control group,while body weight growth velocity was significantly lower(all P<0.05).There was no statistically significant difference in insulin-like growth factor-1(IGF-1)levels between the two groups(P>0.05).Conclusion Huatan Xiehuo Fang as adju-vant therapy in obese girls with CPP of phlegm-heat accumulation pattern can significantly improve glucose and lipid metabolism,imaging indices,sex hormone levels,and growth and development status.It is worthy of clinical promotion and application.
林海波;陈艳妮;侯娟;闫歌;王洋;郝利奇;党巧霞;郑文博;吴参伟;周挺
陕西中医药大学临床医学院,陕西 咸阳 712046||陕西中医药大学第二附属医院儿科,陕西 咸阳 712000西安市儿童医院儿保科,陕西 西安 710000陕西中医药大学第二附属医院儿科,陕西 咸阳 712000陕西中医药大学第二附属医院儿科,陕西 咸阳 712000陕西中医药大学第二附属医院儿科,陕西 咸阳 712000陕西中医药大学第二附属医院儿科,陕西 咸阳 712000陕西中医药大学第二附属医院儿科,陕西 咸阳 712000陕西中医药大学第二附属医院儿科,陕西 咸阳 712000陕西中医药大学第二附属医院超声科,陕西 咸阳 712000陕西中医药大学第二附属医院检验科,陕西 咸阳 712000
医药卫生
中枢性性早熟肥胖女童痰热内蕴证化痰泻火方临床观察
central precocious pubertyobesitygirlsphlegm-heat accumulation patternHuatan Xie-huo Fang(化痰泻火方)clinical observation
《中医儿科杂志》 2026 (2)
49-54,6
秦创原中医药产业创新聚集区项目(L2024-QCY-ZYYJJQ-297).
评论